-
1 Comment
Fate Therapeutics, Inc is currently in a long term uptrend where the price is trading 8.9% above its 200 day moving average.
From a valuation standpoint, the stock is 83.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 219.3.
Fate Therapeutics, Inc's total revenue rose by 467.3% to $16M since the same quarter in the previous year.
Its net income has dropped by 87.7% to $-53M since the same quarter in the previous year.
Finally, its free cash flow grew by 18.4% to $-23M since the same quarter in the previous year.
Based on the above factors, Fate Therapeutics, Inc gets an overall score of 4/5.
| ISIN | US31189P1021 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| Beta | 2.33 |
|---|---|
| Market Cap | 119M |
| PE Ratio | None |
| Target Price | 6.55 |
| Dividend Yield | None |
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FATE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
